Sai Life Sciences (SAILIFE) Stock Overview
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for SAILIFE from our risk checks.
SAILIFE Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Sai Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,457.40 |
| 52 Week High | ₹1,485.00 |
| 52 Week Low | ₹783.85 |
| Beta | 0 |
| 1 Month Change | 16.55% |
| 3 Month Change | 30.85% |
| 1 Year Change | 57.40% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 90.60% |
Recent News & Updates
SAILIFE: Upcoming Board Review And Updated Assumptions Will Shape Measured Outlook
Analysts have lifted their price target on Sai Life Sciences from ₹1,275 to about ₹1,369, citing updated assumptions around revenue growth, discount rate, profit margin and future P/E that feed into their fair value models. What’s in the News for Sai Life Sciences Sai Life Sciences has scheduled a board meeting for August 6, 2026.SAILIFE: Board Review Of Audited Results Will Shape Measured Outlook
Analysts have lifted their price target on Sai Life Sciences from ₹1,082.40 to ₹1,275.00, citing updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations. What's in the News Sai Life Sciences has scheduled a Board Meeting for May 14, 2026, to consider and approve audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2026.Sai Life Sciences (NSE:SAILIFE) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Despite posting some strong earnings, the market for Sai Life Sciences Limited's ( NSE:SAILIFE ) stock hasn't moved...Recent updates
SAILIFE: Upcoming Board Review And Updated Assumptions Will Shape Measured Outlook
Analysts have lifted their price target on Sai Life Sciences from ₹1,275 to about ₹1,369, citing updated assumptions around revenue growth, discount rate, profit margin and future P/E that feed into their fair value models. What’s in the News for Sai Life Sciences Sai Life Sciences has scheduled a board meeting for August 6, 2026.SAILIFE: Board Review Of Audited Results Will Shape Measured Outlook
Analysts have lifted their price target on Sai Life Sciences from ₹1,082.40 to ₹1,275.00, citing updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations. What's in the News Sai Life Sciences has scheduled a Board Meeting for May 14, 2026, to consider and approve audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2026.Sai Life Sciences (NSE:SAILIFE) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Despite posting some strong earnings, the market for Sai Life Sciences Limited's ( NSE:SAILIFE ) stock hasn't moved...Sai Life Sciences Limited (NSE:SAILIFE) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Shareholders might have noticed that Sai Life Sciences Limited ( NSE:SAILIFE ) filed its annual result this time last...Earnings Beat: Sai Life Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
As you might know, Sai Life Sciences Limited ( NSE:SAILIFE ) recently reported its third-quarter numbers. Revenues were...Here's Why We Think Sai Life Sciences (NSE:SAILIFE) Might Deserve Your Attention Today
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Is Sai Life Sciences (NSE:SAILIFE) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Impressive Earnings May Not Tell The Whole Story For Sai Life Sciences (NSE:SAILIFE)
Despite posting some strong earnings, the market for Sai Life Sciences Limited's ( NSE:SAILIFE ) stock hasn't moved...Earnings Beat: Sai Life Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
As you might know, Sai Life Sciences Limited ( NSE:SAILIFE ) just kicked off its latest second-quarter results with...We Think Sai Life Sciences (NSE:SAILIFE) Can Stay On Top Of Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Sai Life Sciences Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
NSEI:SAILIFE 1 Year Share Price vs Fair Value Explore Sai Life Sciences's Fair Values from the Community and select...Sai Life Sciences Limited's (NSE:SAILIFE) Shareholders Might Be Looking For Exit
You may think that with a price-to-sales (or "P/S") ratio of 9.5x Sai Life Sciences Limited ( NSE:SAILIFE ) is a stock...Shareholder Returns
| SAILIFE | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 0.5% | 0.7% | -0.5% |
| 1Y | 57.4% | 22.8% | 1.7% |
Return vs Industry: SAILIFE exceeded the Indian Life Sciences industry which returned 22.8% over the past year.
Return vs Market: SAILIFE exceeded the Indian Market which returned 1.7% over the past year.
Price Volatility
| SAILIFE volatility | |
|---|---|
| SAILIFE Average Weekly Movement | 4.4% |
| Life Sciences Industry Average Movement | 5.5% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.6% |
Stable Share Price: SAILIFE has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: SAILIFE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,401 | Krishnam Kanumuri | www.sailife.com |
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006.
Sai Life Sciences Limited Fundamentals Summary
| SAILIFE fundamental statistics | |
|---|---|
| Market cap | ₹309.14b |
| Earnings (TTM) | ₹3.62b |
| Revenue (TTM) | ₹22.50b |
Is SAILIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAILIFE income statement (TTM) | |
|---|---|
| Revenue | ₹22.50b |
| Cost of Revenue | ₹5.75b |
| Gross Profit | ₹16.76b |
| Other Expenses | ₹13.14b |
| Earnings | ₹3.62b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 17.05 |
| Gross Margin | 74.46% |
| Net Profit Margin | 16.07% |
| Debt/Equity Ratio | 11.6% |
How did SAILIFE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/21 16:59 |
| End of Day Share Price | 2026/08/21 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sai Life Sciences Limited is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jay Gandhi | HDFC Securities Limited |
| Mehul Sheth | HDFC Securities Limited |
| Rahul Jeewani | IIFL Research |